Risks associated with vaccinations;Les risques associes aux vaccinations

Annales de Medecine Interne

Volumn 149, Issue 6, 1998, Pages 361-371

  Loupi, Elisabeth ^a   Baudard, Sylvie ^a   Debois, Henri ^a   Pignato, Françoise ^a  

^a Lab Pasteur Merieux Connaught   (France)

Author keywords

Drug Safety Monitoring; Pharmacovigilance; Risks; Vaccination

Indexed keywords

VACCINE; BACTERIAL VACCINE; VIRUS VACCINE;

DRUG PROGRAM; FOLLOW UP; HUMAN; INFECTION; INFECTION PREVENTION; POSTMARKETING SURVEILLANCE; REVIEW; VACCINATION; ADULT; AGED; AUTOIMMUNE DISEASE; CHILD; CLINICAL TRIAL; COMPARATIVE STUDY; DRUG CONTRAINDICATION; DRUG MONITORING; FEMALE; IMMUNOLOGY; MALE; NEWBORN; RISK FACTOR;

ADULT; AGED; AUTOIMMUNE DISEASES; BACTERIAL VACCINES; CHILD; CLINICAL TRIALS; DRUG MONITORING; FEMALE; HUMANS; INFANT, NEWBORN; MALE; PRODUCT SURVEILLANCE, POSTMARKETING; RISK FACTORS; VACCINATION; VIRAL VACCINES;

EID: 0031751680     PISSN: 0003410X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (99)

1. ROURE C, CELERS J : La poliomyélite en voie d'éradication en France. B E H, 1989 ; 6 : 21-2.
2. LOMBARD I, LEPOUTRE A : Le tétanos en France en 1991 et 1992 (à partir des déclarations obligatoires). B E H, 1993 ; 28 : 125-6.
3. REY M : La part des vaccinations dans le recul des maladies infectieuses. Med Mal Infect, 1997 ; 27 (No Spécial) : 533-6.
4. e siècle. Med Mal Infect, 1997 ; 27 : 490-1.
5. DABIS F, LEVY-BRUHL D, MOREN A : Vaccinologie : vaccins et vaccinations. Cahiers d'études et de recherches francophones, 1994 ; 4(3) : 131-246.
6. SALIOU P, PLOTKIN S : Perspectives en vaccinologie. Cahiers Santé 1994 ; 4 : 237-41.
7. TRON F, MERIEUX C, SALIOU P, DRUCKER J, GIRARD M, REINERT P : Vaccinologie. Rev Prat, 1995 ; 45 : 1473-526.
8. TRON F : La vaccinologie. Entretien avec le Professeur François Tron. Immunol Med, 1992 ; 9(1) : 16-9.
9. DUCLOS P : La surveillance des effets secondaires des vaccins après leur commercialisation. Rev Epidemiol Sante Publ, 1994 ; 42 : 425-33.
10. PLOTKIN S : Les vaccins du futur. Paris : Unesco, 1997.
11. GUERIN N, ROURE C : Calendriers vaccinaux dans les pays de l'Union Européenne. Bull Eur Mal Transm, 1995 ; 7-9.
12. CDC: General recommendations on immunization. Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR, 1994 ; 43(RR-1) : 1-38.
13. Comité technique des vaccinations : Calendrier vaccinal 1996-1997. B E H, 1996 ; (35) : 151-2.
14. Anonymous : Actualisation des recommandations sanitaires pour les voyageurs. B E H, 1996 ; 23 : 101-5.
15. AJJAN N : La vaccination. Lyon : Edition Mérieux MSD Lyon, 1995 : 303.
16. BEYTOUT J: Vaccinations. Bases immunologiques et microbiologiques, indications, contre-indications, accidents, efficacité (calendrier et caractère obligatoire des vaccinations exclus). Rev Prat, 1994 ; 44 : 2487-97.
17. ROUVEIX B : La vaccination: situation actuelle et perspective. La Lettre du Pharmacologue, 1995 ; 9(1) : 7-11.
18. Cox NH, FORSYTH A : Thiomersal allergy and vaccination reactions. Contact Dermatitis, 1988 ; 18 : 229-33.
19. KWITTKEN PL, ROSEN S, SWEINBERG SK: MMR vaccine and neomycin allergy. Am J Dis Child, 1993 ; 147 : 128-9.
20. Ring J : Exacerbation of eczema by formalin-containing hepatitis B vaccine in formaldehyde-allergic patient. Lancet, 1986 ; 522-3.
21. SAKAGUCHI M, OGURA H, INOUYE S : IgE antibody to gelatin in children with immediate-type reactions to measles and mumps vaccines. J Allergy Clin Immunol, 1995 ; 96(4) : 563-5.
22. RUDIN C, GUNTHARD J, HALTER C, STAEHLIN J, BERGLUND A : Anaphylactoid reaction to BCG vaccine containing high molecular weight dextran. Lancet, 1991 ; 337-77.
23. ANDERSON MC, BAER H, FRAZIER DJ, QUINNAN GV : The role of specific IgE and beta-propiolactone in reactions resulting from booster doses of human diploid cell rabies vaccine. J Allergy Clin Immunol, 1987 ; 80(6) : 861-8.
24. GUPTA RK, RELYVELD EH, LINDBLAD EB, BIZZINI B, BEN EFRAIM S, GUPTA CK : Adjuvants - a balance between toxicity and adjuvanticity. Vaccine, 1997 ; 11(3) : 293-306.
25. REINERT P : Vaccins sous unités polysaccharidiques. Rev Prat, 1995 ; (45) : 1484-7.
26. PLOTKIN SA, FLETCHER MA : Combination vaccines and immunization visits. Pediatr Infect Dis J, 1996; 15(2): 103-5.
27. WILLIAMS JC, GOLDENTHAL KL, BURNS DL, LEWIS BPJ : Combined vaccines and simultaneous administration: current issues and perspectives. Ann NY Acad Sci, 1995 ; 754(11-15) : 1-404.
28. GIMENEZ JJ : La vaccination contre l'hépatite B est-elle efficace chez tous ? Infectiol Immunol, 1996 ; 3(4) : 117-20.
29. TRON F : Immunologie de la vaccination. Rev Prat, 1995 ; 45 : 1478-83.
30. BEGG NT : Immunoprophylaxis at extremes of age. J Antimicrob Chemother, 1994 ; 34(Suppl. A) : 121-8.
31. WINTER AP, FOLLETT EAC, MCINTYRE J, STEWART J, SYMINGTON IS : Influence of smoking on immunological responses to hepatitis B vaccine. Vaccine, 1994 ; 12(9) : 771-2.
32. THONGCHAROEN P, WASI C, CHOOMKASIEN P, WATANASRI S, SIRIKAWIN S, MANATSTHITYA S, et al. Failure of protection of tissue-culture rabies vaccines in post-exposure treatment in Thailand - A review. Report of the WHO Consultation on Rabies, Essen, 1988 ; 425.
33. Anonymous : Lignes directrices nationales pour la conservation et le transport des vaccins. Relevé des maladies transmissibles au Canada, 1995 ; 21-11 : 93-104.
34. FESSARD C, RICHE O, COHEN JHM : Intramuscular versus subcutaneous injection for hepatitis B vaccine. Vaccine, 1988 ; 6 : 469-71.
35. APRILE MA, WARDLAW AC : Aluminium compounds as adjuvants for vaccines and toxoids in man: a review. Can J Public Health, 1966 ; 57 : 343-54.
36. COSNES A, FLECHET ML, REVUZ J : Inflammatory nodular reactions after hepatitis B vaccination due to aluminium sensitization. Contact Dermatitis, 1990 ; 23 : 65-7.
37. DURAND C, PINEAU A, BUREAU B, STALDER JF : Complications cutanées des vaccinations diphtérie, tétanos, coqueluche, poliomyélite (Tetracoq). Role de l'hydroxyde d'alumine. Nouv Dermatol, 1992 ; 11 : 523-6.
38. ERSTAD BL, MEEKS ML : Influence of injection site and route on medication absorption. Hospital Pharmacy, 1993 ; 28(9) : 853-78.
39. Anonymous : Intervals between successive doses of killed vaccines: the persistence of immunological memory and implications for the expanded programme on immunization. Relevé Epidem Hebd, 1979 ; 50: 388-9.
40. LE MAIRE JF : Coste : premier médecin des armées de Napoléon. Stock, 1997.
41. MILLER RL: An old malpractice claim. Lancet, 1996, 348-1
42. SALMASO S : Definition of acceptable levels for safety and potential problems. Biologicals, 1994 ; 22 : 407-8.
43. Anonymous : ACIP Issues Update on potential adverse events from vaccines. Am Fam Phys, 1997 ; 55(2) : 702-4.
44. BARBAUD A, SCHMUTZ JL, MOUGEOLLE JM : Réactions immuno-allergiques cutanées dues aux vaccins. Ann Dermatol Venereol, 1995 ; 122 : 129-38.
45. DITTMANN S : Immunobiological preparations. Dukes MNG, editors.Meyler's side effects of drugs. 13th ed. Amsterdam: Elsevier Science B.V., 1996, 32..918-61.
46. DUCLOS P, BENTSI-ENCHILL A : Current thoughts on the risks and benefits of immunisation. Drug Safety, 1993 ; 8 : 404-13.
47. KAPIT RM, GRABENSTEIN JD : Adverse events after immunization: reports and results. Hasp Pharm. 1995 ; 30(11) : 1031-2-5-6-8-41.
48. PLOTKIN SA, MORTIMER E : Vaccines. 2nd ed., Saunders, 1994 : 996
49. REIK L : Neurological complications of immunization. Neurol Infect Epidemiol, 1997 ; 2 : 69-98.
50. Anonymous : Atelier sur la standardisation des définitions pour la surveillance des effets secondaires des vaccins après commercialisation. Ottawa 1991. Relevé des maladies transmissibles au Canada, 1992 ; 18(S2) : 1-17.
51. BALRAJ V, MILLER E : Complications of mumps vaccines. Rev Med Virol, 1995 ; 5 : 219-27.
52. BOOY R, HEATH PT, SLACK MPE, BEGG N, MOXON ER : Vaccine failures after primary immunisation with Haemophilus influenzae type-b conjugate vaccine without booster. Lancet, 1997 ; 349(9060) : 1197-202.
53. WILDE H, CHOOMKASIEN P, HEMACHUDHA T, SUPICH C, CHUTIVONGSE S : Failure of rabies postexposure treatment in Thailand. Vaccine, 1989 ; 7: 49-52.
54. MESSIAH A, FLAHAUT A : Absence de liaison entre la vaccination tétravalente et le syndrome de mort subite du nourrisson. B E H, 1986 ; 52 : 205-6.
55. CARVAJAL A, CARO-PATON T, MARTIN DE DIEGO I, MARTIN ARIAS LH, ALVAREZ REQUEJO A, LOBATO A : Vacuna DTP y sindrome de muerte subita del lactante. Un metaanalisis. Med Clin, 1996 ; 106(17) : 649-52.
56. MITCHELL EA, STEWART AW, CLEMENTS M, FORD RPK : Immunisation and the sudden infant death syndrome. Arch Dis Childhood, 1995 ; 73 : 498-501.
57. Anonymous : Circulaire du 27 décembre, 1985. Relative aux contre-indications aux vaccinations. B E H, 1986 ; 4 : 14-5.
58. CADOZ M, LOUPI E : Vaccins viraux et grossesse, 1997.
59. American Academy of Pediatrics, Committee on Infectious Diseases. Peter G, editor. Vaccine safety and contraindications (Red Book). 23th ed., 1994 : 29 p.
60. BOUCHAUD O : Vaccinations chez les patients immunodéprimés. Ann Med Interne, 1997 ; 148(3) : 272-9.
61. CDCP : Recommendations of the Advisory Committee on Immunization Practices (ACIP): use of vaccines and immunoglobulins for HIV-infected persons with altered immunocompetence. MMWR, 1993 ; 42(RR-4) : 1-8.
62. COHEN AD, SHOENFELD Y : Vaccine-induced autoimmunity. Autoimmunity, 1996 ; 9 : 699-703.
63. HANSLIK T, BOULARD JC, BAGLIN A : Vaccination et maladies immunologiques. Rev Med Interne, 1996 ; 17 : 17-20.
64. KAHN MF : Vaccination et polyarthrite rhumatoïde. Rev Rhum (suppl Pédagogique), 1997 ; 64(4) : 169-70.
65. QUAST U, HERDER C, ZWISLER O : Vaccination of patients with encephalomyelitis disseminata. Vaccine, 1991 ; 9 : 229-30.
66. Anonymous : Vaccine drug interactions. Drug Intellig Clin Pharmacy, 1984 ; 18 : 697-700.
67. D'ARCY PF : Drug interactions reactions update. Vaccine-drug interactions. Drug Intellig Clin Pharmacy, 1984 ; 18 : 697-700.
68. GIZURARSON S : Optimal delivery of vaccines. Clinical Pharmacokinetic considerations. Clin Pharmacokinet, 1996; 30(1) : 1-15.
69. GRABENSTEIN JD : Drug interactions involving immunologic agents. Part I vaccine-vaccine, vaccine-immunoglobulin, and vaccine-drug interactions. DICP, Annals Pharmacotherapy, 1990 ; 24 : 67-81.
70. OCHS HD : Steroids and immunizations. Pediatr Infect Dis J. 1994 ; 13(8) : 760.
71. GOMOLIN IH, CHARRON DJ, LUHAN PA : Lack of effect of influenza vaccine on theophylline levels and warfarin anticoagulation in the elderly. J Am Geriatr Soc, 1985 ; 33(4) : 269-72.
72. HAMDY RC, MICKLEWRIGHT M, BEECHAM VF, MOORE SW : Influenza vaccine may enhance theophylline toxicity. A case report and review of the literature. J Tennessee Med Assoc, 1995 ; 88(12) : 463-4.
73. PAPPAIOANOU M, FISHBEIN DB, DREESEN DW, SCHWARTZ IK, CAMPBELL GH, SUMNER JW, et al. Antibody response to preexposure human diploid-cell rabies vaccine given concurrently with chloroquine. N Engl J Med, 1986 ; 314(5) : 280-4.
74. FESCHAREK R, FRANKE V, SAMUEL MR : Do anaesthetics and surgical stress increase the risk of post-exposure rabies treatment failure ? Vaccine, 1994 ; 12(1) : 12-3.
75. HOROWITZ H, CARBONARO CA : Inhibition of the Salmonella typhi oral vaccine strain Ty21a, by mefloquine and chloroquine. J Infect Dis, 1992 ; 166 : 1462-4.
76. NKOWANE BM, WASSILAK SG, ORENSTEIN WA, BART K, J., SCHONBERGER LB, HINMAN AR : Vaccine associated paralytic poliomyelitis, United States, 1973 through 1984. J Am Med Assoc, 1987 ; 257 : 1335-40.
77. TSAI TF, PAUL R, LYNBERG MC : Congenital yellow fever virus infection after immunization in pregnancy. J Infect Dis, 1993 ; 168 : 1520-3.
78. SALZMAN MB, SHARRAR RG, STEINBERG S, LARUSSA P : Transmission of varicella-vaccine virus from a healthy 12-month- old child to his pregnant mother. J Pediatr, 1997 ; 131(1-Part 1) : 151-4.
79. CHEN RT, BRIAN L. STROM : Pharmacoepidemiology; 1994; 2nd ed. Special methodological issues in Pharmacoepidemiology studies of vaccine safety.
80. CHEN RT, RASTOGI SC, MULLEN JR, HAYES SW, COCHI SL, DONLON JA, et al. The Vaccine Adverse Event Reporting System (VAERS). Vaccine, 1994 ; 12(6) : 542-50.
81. ROSENTHAL S, CHEN R : The reporting sensitivities of two passive surveillance systems for vaccine adverse events. Am J Public Health, 1995 ; 85(12) : 1706-9.
82. Anonymous : Adverse events temporally associated with vaccines. 1992 Report. Canada Communicable Disease Report, 1995 ; 21(13) : 117-28.
83. DUCLOS P, PLESS R, KOCH J, HARDY M : Adverse events temporally associated with immunizing agents. Canadian Family Physician, 1993 ; 39 : 1907-13.
84. FINE PEM, CHEN RT : Confounding in studies of adverse reactions to vaccines. Am J Epidemiol, 1992 ; 136(2) : 121-35.
85. REBIERE I, GALY-EYRAUD C : Estimation of the risk of aseptic meningitis associated with mumps vaccination, France, 1991-1993. Int J Epidemiol, 1995 ; 24(6) : 1223-7.
86. FARRINGTON CP, NASH J, MILLER E : Case series analysis of adverse reactions to vaccines, a comparative evaluation. Am J Epidemiol, 1996 ; 143(11) : 1165-73.
87. NASH JQ, CHANDRAKUMAR M, FARRINGTON CP, WILLIAMSON S, MILLER E : Feasibility study for identifying adverse events attributable to vaccination by record linkage. Epidemiol Infect, 1995 ; 114 : 475-80.
88. BEGAUD B, EVREUX JC, JOUGLARD J, LAGIER G : Imputabilité des effets inattendus ou toxiques des médicaments. Actualisation de la méthode utilisée en France. Thérapie, 1985 ; 40 : 111-8.
89. KRAMER MS, LEVENTHAL JM, HUTCHINSON TA, FEINSTEIN AR: An algorithm for the operational assessment of adverse drug reactions. Jama, 1979 ; 242(7) : 623-42.
90. VENULET J, CIUCCI A, BERNEKER GC : Standardized assessment of drug-adverse reaction associations-rationale and experience. International Journal of Clinical Pharmacology. Therapy Toxicol, 1980 ; 18(9) : 381-8.
91. FENICHEL GM, LANE DA, LIVENGOOD JR, HOROWITZ SJ, MENKES JH, SCHWARTZ JF: Adverse events following immunization: assessing probability of causation. Pediatr Neurol, 1989 ; 5: 287-90.
92. WASSILAK SGF, GLASSER JW, CHEN RT, HADLER SC : Utility of large-linked databases in vaccine safety, particularly in distinguishing independent and synergistic effects. Ann N Y Acad Sci, 1995 : 377-82.
93. AURICHE M, LOUPI E : Does proof of causality ever exist in pharmacovigilance? Drug Safety, 1993 ; 9(3) : 230-5.
94. STRATTON KR, HOWE CJ, JOHNSTON RB : Adverse events associated with childhood vaccines other than pertussis and rubella. Summary of a report from the Institut Of Medicine. Jama, 1994 ; 271(20) : 1602-5.
95. STRATTON KR, HOWE CJ, JOHNSTON RB, STRATTON KR, HOWE CJ, JOHNSTON RB, editors : Adverse events associated with childhood vaccines. Evidence bearing on causality. Washington,D.C. Institut of Medicine; 1994 ; 8 : 211-34.
96. PLOTKIN SA, LOUPI E, LANG J : Bali low. Pediatrics, 1997 ; 100 : 718-9.
97. CDC : Update : vaccine side effects, adverse reactions, contraindications, and precautions. Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR, 1996 ; 45(RR-12) : 1-35.
98. CHEN RT, HABER P, MULLEN JR : Surveillance of the safety of simultaneous administration of vaccines. The Centers for Disease Control and Prevention Experience. Ann N Y Acad Sci, 1995 ; 309-20.
99. EVANS G : National Childhood Vaccine Injury Act: revision of the vaccine injury table. Pediatrics, 1996 ; 98(6) : 1179-81.